The Centre's ambition is to support novel technologies bringing solutions to unmet needs along the patient journey. In early detection, we focus our efforts on bringing the continued development of ultrasensitive low-cost devices to detect specific early disease signals, supported by clinical positioning and adoption strategies. We will bring to the clinic novel interventions as well as improving standards, such as in surgery to optimise surgical precision through robotics, imaging and margin monitoring tools. As modern devices need heavy data processing and analysis, we will support both hardware and software development through our Data Science initiative to connect new devices to achieve real-time analysis and smarter processing. For novel interventions, we will continue to develop technologies and methodologies to improve strategies for local control of advanced-stage cancers. Through our Clinical Development initiative, we expect to accelerate new drug and medical device approvals. To drive uptake and adoption of our innovations within the NHS, we wish to address the regulatory challenges associated with novel interventions. We provide expertise in Implementation Science, Human Factors and Health Economics.